InsiderDB
Sign inStart free trial

Sen. Sheldon Whitehouse bought Bristol-Myers Squibb Company (BMY)

Sen. Sheldon Whitehouse (D-RI) · $1K–$15K · traded Feb 23, 2017

Transaction
Bought
Amount
$1K–$15K
Owner
Dependent
Traded
Feb 23, 2017
Disclosed
Mar 15, 2017
Days to disclose
20
Asset type
Stock
As filed
Bristol-Myers Squibb Company
Industry
Drug Manufacturers - General · Healthcare
Official filing ↗All of Whitehouse's tradesAll Congress trades in BMY

Other trades in this filing

Recent Congress trades in BMY

Company context for BMY

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. BMYFinancial report·SEC EDGAR

    BMY: 10-Q financial filing

    Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.

    Public: Oct 29, 2026, 11:16 AM EDTEvent / period: Sep 30, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  2. BMYCompany announcement·SEC EDGAR

    BMY: Financial results · Company disclosure

    Filed 8-K for an event or period dated 2026-10-29. Financial results; Company disclosure.

    Public: Oct 29, 2026, 7:05 AM EDTEvent / period: Oct 29, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  3. BMYLobbying report·Lobbying disclosures

    BMY: third_quarter 2026 lobbying report

    Access to prescription drugs. Policies related to 340B. Drug Pricing reform/implementation. Food is Medicine initiatives. Issues related to the budget and appropriations process

    Public: Oct 20, 2026, 11:15 PM EDTOriginal source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.